181 related articles for article (PubMed ID: 28674565)
1. [Anorectal adenocarcinoma after Infliximab treatment for fistulizing Crohn's disease].
Smaali J; Sekkach Y
Pan Afr Med J; 2017; 26():172. PubMed ID: 28674565
[No Abstract] [Full Text] [Related]
2. An unusual case of anorectal carcinoma in a patient with Crohn's disease.
Narilli P; Lai Q; Meo D
J Crohns Colitis; 2010 Jun; 4(2):219-20. PubMed ID: 21122512
[No Abstract] [Full Text] [Related]
3. Adenocarcinoma arising from chronic perianal crohn's disease: a case report.
Massit H; Edderai M; Saouab R; Seddik H; El Fenni J; Benkirane A
Pan Afr Med J; 2015; 22():140. PubMed ID: 26889321
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma associated with perianal fistulas in Crohn's disease.
Ogawa H; Haneda S; Shibata C; Miura K; Nagao M; Ohnuma S; Kohyama A; Unno M
Anticancer Res; 2013 Feb; 33(2):685-9. PubMed ID: 23393368
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma arising in anorectal fistulas of Crohn's disease.
Kulaylat MN; Gallina G; Bem J; Zeid M
Dis Colon Rectum; 1999 Jun; 42(6):826-8. PubMed ID: 10378613
[No Abstract] [Full Text] [Related]
6. A perianal mass in a Crohn's disease patient.
Bautista JM; Marín-Jiménez I; Moreno LH
Gastroenterology; 2012 Jan; 142(1):12, 187. PubMed ID: 22107710
[No Abstract] [Full Text] [Related]
7. Perianal Crohn's disease and fistula-associated carcinoma: challenges in diagnosis.
Zefelippo A; Costa S; Caprioli F; Contessini-Avesani E
Int J Colorectal Dis; 2015 Nov; 30(11):1589-91. PubMed ID: 25643850
[No Abstract] [Full Text] [Related]
8. Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
Chiba M; Tsuji T; Nakane K; Obara Y; Komatsu M
Inflamm Bowel Dis; 2020 Jan; 26(1):e4. PubMed ID: 31697829
[No Abstract] [Full Text] [Related]
9. Carcinoma arising in anorectal fistulas of Crohn's disease.
Ky A; Sohn N; Weinstein MA; Korelitz BI
Dis Colon Rectum; 1998 Aug; 41(8):992-6. PubMed ID: 9715154
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression may exert a hypoxia-mediated carcinogenetic effect in long-standing fistulizing Crohn's disease.
Pellino G
Eur J Gastroenterol Hepatol; 2014 May; 26(5):575-6. PubMed ID: 24694737
[No Abstract] [Full Text] [Related]
11. Anorectal cancer in Crohn's disease: a rare entity.
Solis E; Reza F; Toh JWT; El-Khoury T
ANZ J Surg; 2021 Apr; 91(4):E223-E224. PubMed ID: 32846038
[No Abstract] [Full Text] [Related]
12. Adenocarcinoma arising within a Crohn's-related anorectal fistula: a form of anal gland carcinoma?
Wong NA; Shirazi T; Hamer-Hodges DW; Corfield AP; Lessells AM
Histopathology; 2002 Mar; 40(3):302-4. PubMed ID: 11895502
[No Abstract] [Full Text] [Related]
13. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
14. Anal and rectal cancer in Crohn's disease.
Sjödahl RI; Myrelid P; Söderholm JD
Colorectal Dis; 2003 Sep; 5(5):490-5. PubMed ID: 12925087
[TBL] [Abstract][Full Text] [Related]
15. Perianal eccrine hydroadenocarcinoma in the context of a fistulising Crohn's disease.
Pareja-López Á; Ferrer-Márquez M; Berenguel-Ibáñez MDM; Espínola-Cortés N; Velasco-Albendea FJ
Gastroenterol Hepatol; 2018; 41(7):450-452. PubMed ID: 28827020
[No Abstract] [Full Text] [Related]
16. Adenocarcinoma arising from chronic perianal Crohn's disease: case report and review of the literature.
Smith R; Hicks D; Tomljanovich PI; Lele SB; Rajput A; Dunn KB
Am Surg; 2008 Jan; 74(1):59-61. PubMed ID: 18274431
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
[TBL] [Abstract][Full Text] [Related]
18. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
[TBL] [Abstract][Full Text] [Related]
19. [A case of anal cancer with rapidly rising CEA in longstanding perianal Crohn disease after infliximab administration].
Sato M; Ogawa H; Shibata C; Miura K; Ando T; Saijo F; Haneda S; Kakyo M; Kinouchi M; Fukushima K; Funayama Y; Takahashi K; Sasaki I
Nihon Shokakibyo Gakkai Zasshi; 2010 Jun; 107(6):885-92. PubMed ID: 20530924
[TBL] [Abstract][Full Text] [Related]
20. Is Hartmann's procedure safe in Crohn's disease? Report of three cases.
Cirincione E; Gorfine SR; Bauer JJ
Dis Colon Rectum; 2000 Apr; 43(4):544-7. PubMed ID: 10789755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
